RG-1068 RepliGen

Curr Opin Investig Drugs. 2003 Jan;4(1):66-71.

Abstract

RG-1068 is a synthetic form of the natural human hormone secretin under development by RepliGen for the potential treatment of autism. RG-1068 received Fast Track designation for the treatment of pediatric autism in September 2001, and in February 2002, it entered phase III clinical trials.

Publication types

  • Review

MeSH terms

  • Animals
  • Autistic Disorder / drug therapy*
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Humans
  • Secretin / pharmacology*
  • Secretin / therapeutic use*

Substances

  • Secretin